PL1981506T6 - Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278 - Google Patents

Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278

Info

Publication number
PL1981506T6
PL1981506T6 PL07712053T PL07712053T PL1981506T6 PL 1981506 T6 PL1981506 T6 PL 1981506T6 PL 07712053 T PL07712053 T PL 07712053T PL 07712053 T PL07712053 T PL 07712053T PL 1981506 T6 PL1981506 T6 PL 1981506T6
Authority
PL
Poland
Prior art keywords
tcm278
hiv
infection
long term
term treatment
Prior art date
Application number
PL07712053T
Other languages
English (en)
Other versions
PL1981506T3 (pl
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
Gerben Albert Eleutherius Van 't Klooster
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1981506(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of PL1981506T3 publication Critical patent/PL1981506T3/pl
Publication of PL1981506T6 publication Critical patent/PL1981506T6/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07712053T 2006-01-20 2007-01-19 Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278 PL1981506T6 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278
EP07712053.3A EP1981506B3 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
PL1981506T3 PL1981506T3 (pl) 2013-08-30
PL1981506T6 true PL1981506T6 (pl) 2021-07-12

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07712053T PL1981506T6 (pl) 2006-01-20 2007-01-19 Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278

Country Status (27)

Country Link
US (4) US10953009B2 (pl)
EP (1) EP1981506B3 (pl)
JP (2) JP5754005B2 (pl)
KR (2) KR101562943B1 (pl)
CN (2) CN103877091A (pl)
AP (1) AP2936A (pl)
AR (1) AR059097A1 (pl)
AU (1) AU2007206901B2 (pl)
BR (1) BRPI0707179A2 (pl)
CA (1) CA2636436C (pl)
CY (1) CY1114089T1 (pl)
DK (1) DK1981506T6 (pl)
EA (1) EA014914B1 (pl)
ES (1) ES2414982T7 (pl)
HR (1) HRP20130544T4 (pl)
IL (1) IL192132A (pl)
ME (1) ME01617B (pl)
MY (1) MY150717A (pl)
NZ (1) NZ569347A (pl)
PL (1) PL1981506T6 (pl)
PT (1) PT1981506E (pl)
RS (1) RS52821B2 (pl)
SG (1) SG170073A1 (pl)
SI (1) SI1981506T1 (pl)
TW (1) TWI458483B (pl)
UA (1) UA96436C2 (pl)
WO (1) WO2007082922A2 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
PL1981506T6 (pl) 2006-01-20 2021-07-12 Janssen Sciences Ireland Uc Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278
SI3366278T1 (sl) * 2006-06-23 2024-12-31 Janssen Sciences Ireland Unlimited Company Vodne suspenzije tmc278
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
TWI494133B (zh) 2007-03-14 2015-08-01 Tibotec Pharm Ltd 重組用粉末
NZ593950A (en) 2008-12-24 2013-08-30 Janssen R & D Ireland Implantable devices for treating hiv
EP2480220B1 (en) * 2009-09-22 2014-11-19 Janssen R&D Ireland Treatment and prevention of hiv infection
US8784858B2 (en) 2009-12-21 2014-07-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
EA032868B1 (ru) 2010-01-27 2019-07-31 Вайв Хелткер Компани Комбинация для лечения вич-инфекции
TWI577377B (zh) * 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
KR102673927B1 (ko) * 2015-11-16 2024-06-10 에보닉 오퍼레이션스 게엠베하 비-뉴클레오시드 역전사 효소 저해제 및 폴리(락티드-코-글리콜리드)를 포함하는 주사 용액
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6045829A (en) 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
CA2383233C (en) 1999-09-21 2010-06-08 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
EP1267879A2 (en) 2000-03-30 2003-01-02 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
US20040115268A1 (en) 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
CA2465779A1 (en) 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions for sustained action product delivery
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
EP1525216A4 (en) * 2002-01-24 2009-07-08 Sangstat Medical Corp COMBINATION THERAPY FOR THE TREATMENT OF HIV INFECTION
ATE361059T1 (de) 2002-11-08 2007-05-15 Glaxo Group Ltd Antivirale zusammensetzungen
JP4733393B2 (ja) 2002-11-18 2011-07-27 ポラリス・グループ インビボでウイルス複製を阻害する方法
KR20110132482A (ko) 2003-02-07 2011-12-07 얀센 파마슈티카 엔.브이. Ｈｉｖ 감염 예방용 피리미딘 유도체
WO2004073703A1 (en) 2003-02-21 2004-09-02 Tripep Ab Glycinamide derivative for inhibiting hiv replication
PL1632232T6 (pl) * 2004-09-02 2022-06-27 Janssen Pharmaceutica Nv Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
CN104586850A (zh) 2004-09-02 2015-05-06 詹森药业有限公司 4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的盐酸盐
EA200701065A1 (ru) 2004-11-16 2007-12-28 Элан Фарма Интернэшнл Лтд. Инъецируемые составы, содержащие нанодисперсный оланзапин
TW201414495A (zh) * 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
PL1981506T6 (pl) 2006-01-20 2021-07-12 Janssen Sciences Ireland Uc Długoterminowe leczenie zakażenia HIV z zastosowaniem TCM278
SI3366278T1 (sl) 2006-06-23 2024-12-31 Janssen Sciences Ireland Unlimited Company Vodne suspenzije tmc278
DK2175857T3 (da) 2007-07-12 2013-12-02 Janssen R & D Ireland Krystallinsk form af (e) 4-[[4-[[4-(2-cyanoethenyl)-2.6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitril

Also Published As

Publication number Publication date
IL192132A0 (en) 2009-08-03
AU2007206901A1 (en) 2007-07-26
KR20080085194A (ko) 2008-09-23
HK1125828A1 (en) 2009-08-21
BRPI0707179A2 (pt) 2011-04-26
JP5754005B2 (ja) 2015-07-22
JP2013100338A (ja) 2013-05-23
CN101370504A (zh) 2009-02-18
KR101501475B1 (ko) 2015-03-19
US20110275654A1 (en) 2011-11-10
ES2414982T3 (es) 2013-07-23
TW200806295A (en) 2008-02-01
AR059097A1 (es) 2008-03-12
JP2009526758A (ja) 2009-07-23
WO2007082922A8 (en) 2008-01-03
EP1981506B3 (en) 2021-06-09
IL192132A (en) 2014-05-28
ES2414982T7 (es) 2021-11-05
JP5836983B2 (ja) 2015-12-24
EP1981506A2 (en) 2008-10-22
NZ569347A (en) 2011-07-29
DK1981506T3 (da) 2013-06-24
CA2636436C (en) 2014-04-01
MY150717A (en) 2014-02-28
ME01617B (me) 2014-09-20
HRP20130544T4 (hr) 2021-08-20
CA2636436A1 (en) 2007-07-26
CY1114089T1 (el) 2016-07-27
SI1981506T1 (sl) 2013-08-30
PL1981506T3 (pl) 2013-08-30
KR101562943B1 (ko) 2015-10-23
KR20140141699A (ko) 2014-12-10
RS52821B (sr) 2013-10-31
RS52821B2 (sr) 2021-07-30
AP2008004535A0 (en) 2008-08-31
UA96436C2 (ru) 2011-11-10
HRP20130544T1 (en) 2013-07-31
PT1981506E (pt) 2013-06-25
CN103877091A (zh) 2014-06-25
US10953009B2 (en) 2021-03-23
DK1981506T6 (da) 2021-06-14
US20240226099A1 (en) 2024-07-11
WO2007082922A3 (en) 2007-09-20
WO2007082922A2 (en) 2007-07-26
AP2936A (en) 2014-07-31
SG170073A1 (en) 2011-04-29
TWI458483B (zh) 2014-11-01
EA200870183A1 (ru) 2009-12-30
USRE50189E1 (en) 2024-10-29
EP1981506B1 (en) 2013-03-27
US20210177843A1 (en) 2021-06-17
AU2007206901B2 (en) 2013-01-31
EA014914B1 (ru) 2011-02-28

Similar Documents

Publication Publication Date Title
IL192132A0 (en) Long term treatment of hiv-infection with tcm278
HUS1800011I1 (hu) Kombinációs terápia szubsztituált oxazolidinonokkal
GB0610867D0 (en) Treatment of pain
IL193748A0 (en) Treatment of pain
GB0624874D0 (en) Treatment
GB0702931D0 (en) Skin application
GB0909297D0 (en) Composition for the treatment of skin conditions
GB0600692D0 (en) Well treatment
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
ZA200806505B (en) Treatment of HIV
GB0723100D0 (en) Treatment of HFnEF
GB0610868D0 (en) Treatment of pain
GB0607952D0 (en) Novel treatment
GB0604460D0 (en) Treatment
GB0714500D0 (en) composition and treatment
GB0616450D0 (en) Treatment of pain
GB0602857D0 (en) The treatment of sialorrhoea
GB0623740D0 (en) Treatment of disease
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea
GB0625602D0 (en) Treatment of sialorrhoea
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0610431D0 (en) Treatment
GB0605781D0 (en) Treatment
GB0609789D0 (en) Treatment of inflammation